Russell Investments Group, Ltd. X4 Pharmaceuticals, Inc Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$0.58 - $1.47 $1,102 - $2,794	1,901 New	1,901 $1,000
Q2 2021 Aug 04, 2021	SELL	$6.49 - $9.56 $44,041 - $64,874	-6,786 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$5.41 - $7.4 $108,919 - $148,984	-20,133 Reduced 74.79%	6,786 $43,000
Q3 2020 Nov 09, 2020	BUY	$6.09 - $9.15 $163,936 - $246,308	26,919 New	26,919 $182,000
Q4 2019 Jan 29, 2020	SELL	$9.93 - $14.33 $104,165 - $150,321	-10,490 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$11.06 - $15.75 $116,019 - $165,217	10,490 New	10,490 $133,000

99.6M

421K

80.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $32.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.